Matinas Financial Statements From 2010 to 2025

Matinas BioPharma Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 12 M 12.6 M 23.1 M Slightly volatile Other Current Liabilities 1.6 M 1.8 M 1.3 M Slightly volatile Total Current Liabilities 2.6 M 2.7 M 2.1 M Slightly volatile Total Stockholder Equity 7.2 M 7.6 M 17.1 M Slightly volatile Accounts Payable 90.2 K 95 K 374 K Slightly volatile Cash 9.8 M 7.3 M 7.9 M Slightly volatile Cash And Short Term Investments 6.9 M 7.3 M 14.7 M Slightly volatile Common Stock Shares Outstanding 4.6 M 4.9 M 11.9 M Very volatile Total Liabilities 7.7 M 5.1 M 6.2 M Slightly volatile Total Current Assets 7.6 M 8 M 15.8 M Slightly volatile Common Stock 950 1000 9.1 K Slightly volatile Property Plant And Equipment Net 3.1 M 2.2 M 2.3 M Slightly volatile Non Current Assets Total 4.4 M 4.6 M 7.4 M Slightly volatile Common Stock Total Equity 13 K 25.3 K 11.8 K Slightly volatile Liabilities And Stockholders Equity 12 M 12.6 M 25.2 M Slightly volatile Other Current Assets 704 K 741 K 1.1 M Slightly volatile Other Stockholder Equity 117.6 M 207.4 M 90.2 M Slightly volatile Property Plant And Equipment Gross 3.5 M 4.2 M 2.6 M Slightly volatile Short and Long Term Debt Total 2.4 M 2.9 M 1.7 M Slightly volatile Other Assets 2.9 M 3.7 M 2.2 M Slightly volatile Long Term Debt 130 K 123.8 K 67.2 K Slightly volatile Long Term Debt Total 57.6 K 62.7 K 42.3 K Slightly volatile Non Current Liabilities Total 2.3 M 2.4 M 3.9 M Slightly volatile Capital Surpluse 229.5 M 218.6 M 98 M Slightly volatile Capital Lease Obligations 2.6 M 2.9 M 1.6 M Slightly volatile Deferred Long Term Liabilities 291.6 K 306.9 K 1.6 M Slightly volatile Long Term Investments 132.7 K 103.8 K 147.3 K Slightly volatile Short and Long Term Debt 123 K 229.8 K 134.4 K Slightly volatile Short Term Debt 412.1 K 766 K 294.4 K Slightly volatile Property Plant Equipment 2.3 M 2.4 M 1.7 M Slightly volatile Other Liabilities 291.6 K 306.9 K 843.7 K Slightly volatile Intangible Assets 2.4 M 2.3 M 2.9 M Slightly volatile Preferred Stock Total Equity 4.7 M 3.4 M 5.3 M Slightly volatile Non Current Liabilities Other 3.1 M 4.1 M 2.4 M Slightly volatile Net Invested Capital 7.2 M 7.6 M 16.2 M Slightly volatile Net Working Capital 5.1 M 5.4 M 15.1 M Slightly volatile Capital Stock 950 1000 6 M Slightly volatile Net Receivables 520 K 585 K 637.8 K Slightly volatile
Matinas BioPharma Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 1 M 972 K 312.1 K Slightly volatile Selling General Administrative 7.6 M 8.7 M 6.1 M Slightly volatile Other Operating Expenses 17.7 M 24.6 M 14.2 M Slightly volatile Research Development 9.7 M 11.4 M 7.8 M Slightly volatile Total Operating Expenses 12.9 M 24.6 M 10.4 M Slightly volatile Cost Of Revenue 923.4 K 972 K 7.5 M Slightly volatile Non Operating Income Net Other 4.3 M 4.1 M 1.4 M Slightly volatile Interest Income 653.6 K 622.5 K 262.2 K Slightly volatile Reconciled Depreciation 749.8 K 972 K 431.7 K Slightly volatile Preferred Stock And Other Adjustments 437.2 K 356.2 K 678.8 K Slightly volatile Selling And Marketing Expenses 752.8 K 846.9 K 923.4 K Slightly volatile
Matinas BioPharma Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 9.4 M 5 M 7.5 M Slightly volatile Other Non Cash Items 4.6 M 4.4 M 1.2 M Slightly volatile End Period Cash Flow 10 M 7.5 M 8 M Slightly volatile Stock Based Compensation 3.5 M 3.2 M 2.7 M Slightly volatile Depreciation 513.9 K 972 K 382.7 K Slightly volatile Change To Account Receivables 36.5 K 41.1 K 44.8 K Slightly volatile Change To Netincome 3.6 M 6 M 3.3 M Slightly volatile Change Receivables 36.5 K 41.1 K 44.8 K Slightly volatile Dividends Paid 1.2 B 759.2 M 2.5 B Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 36.64 38.57 945 Pretty Stable Dividend Yield 4.34 4.57 26.6913 Slightly volatile PTB Ratio 0.31 0.327 11.3359 Slightly volatile Book Value Per Share 1.48 1.5599 6.6961 Pretty Stable Average Payables 351.3 K 579.1 K 438.8 K Slightly volatile Stock Based Compensation To Revenue 3.86 4.06 20.8772 Pretty Stable Capex To Depreciation 0.25 0.27 22.8496 Slightly volatile PB Ratio 0.31 0.327 11.3359 Slightly volatile EV To Sales 35.68 37.56 879 Pretty Stable Payables Turnover 13.97 10.2316 17.6484 Very volatile Sales General And Administrative To Revenue 8.09 8.52 50.1207 Pretty Stable Research And Ddevelopement To Revenue 11.3 11.9 64.688 Pretty Stable Capex To Revenue 0.22 0.23 2.0436 Very volatile Cash Per Share 1.42 1.497 5.8378 Very volatile Days Payables Outstanding 33.89 35.6739 252 Very volatile Income Quality 0.59 0.655 0.7037 Pretty Stable Intangibles To Total Assets 0.24 0.1788 0.3126 Slightly volatile Net Debt To EBITDA 0.18 0.1879 1.0361 Slightly volatile Current Ratio 5.56 3.0101 6.6253 Pretty Stable Tangible Book Value Per Share 1.04 1.0954 5.4974 Very volatile Shareholders Equity Per Share 1.48 1.5599 6.6961 Pretty Stable Debt To Equity 0.4 0.3813 0.0975 Slightly volatile Capex Per Share 0.0548 0.0577 0.1874 Slightly volatile Graham Net Net 0.44 0.4589 4.2986 Very volatile Revenue Per Share 0.14 0.23 0.1748 Pretty Stable Interest Debt Per Share 0.47 0.5948 0.4568 Slightly volatile Debt To Assets 0.24 0.2289 0.0675 Slightly volatile Price Book Value Ratio 0.31 0.327 11.3359 Slightly volatile Days Of Payables Outstanding 33.89 35.6739 252 Very volatile Ebt Per Ebit 0.78 1.2028 0.9603 Pretty Stable Effective Tax Rate 0.0502 0.0816 0.0508 Slightly volatile Company Equity Multiplier 1.04 1.6655 1.2757 Very volatile Long Term Debt To Capitalization 1.09 1.14 1.0058 Slightly volatile Total Debt To Capitalization 0.29 0.276 0.0796 Slightly volatile Debt Equity Ratio 0.4 0.3813 0.0975 Slightly volatile Quick Ratio 5.56 3.0101 6.6253 Pretty Stable Net Income Per E B T 0.97 0.71 0.9018 Slightly volatile Cash Ratio 4.65 2.7322 4.3541 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.13 1.17 1.0497 Slightly volatile Price To Book Ratio 0.31 0.327 11.3359 Slightly volatile Fixed Asset Turnover 0.15 0.2 0.2822 Slightly volatile Debt Ratio 0.24 0.2289 0.0675 Slightly volatile Price Sales Ratio 36.64 38.57 945 Pretty Stable Asset Turnover 0.0413 0.0393 0.0229 Slightly volatile Price Fair Value 0.31 0.327 11.3359 Slightly volatile
Matinas BioPharma Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 2.4 M 2.5 M 165.4 M Slightly volatile

Matinas Fundamental Market Drivers

Matinas Upcoming Events

About Matinas BioPharma Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Matinas BioPharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Matinas BioPharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Matinas Biopharma Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Matinas Biopharma Holdings Stock:

How To Invest In Matinas Details

Is Matinas Stock a good investment? Details

What is Matinas BioPharma's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details